Observational Study of the association of GGT with Benign and Malignant Breast Tumors
Observational Study of the association of GGT with Benign and Malignant Breast Tumors
DOI:
https://doi.org/10.70284/njirm.v8i4.1280Keywords:
Carcinoma breast, Fibroadenoma, Gamma glutamyl transferase, Glutathione, MetastasisAbstract
Background: Gamma-glutamyltransferase (GGT) is a cell surface enzyme that uniquely enables glutathione catabolism by hydrolysing the gamma glutamyl bond between glutamate and cysteine. GGT is one of the enzymes which may rise in malignancies and since being economic and relatively easier to determine, remain as useful and practical marker in terms of prognosis and also early diagnosis. Breast cancer is a major public health issue in India. Most cases of Breast cancer in India are diagnosed at advanced stage, and outcome is not as good as earlier stages, most important reason being lack of screening and awareness. The objective of present study was to assess the clinical utility of serum levels of GGT in cases of breast lesions and to evaluate whether their levels are significantly higher in cases of breast malignancies as compared to cases of benign breast lesions. Methods: A total number of 160 subjects were studied, comprising of 80 cases of benign breast lesions and 80 Breast cancer subjects. Breast cancer subjects were further divided depending on stage of the cancer. Serum level of GGT was estimated in all subjects. Results: The present observational study has shown a significant elevation in serum levels of GGT in cases of carcinoma Breast as compared to benign breast lesions. These levels raised significantly with severity (stage) of carcinoma Breast. Conclusion: This study concludes that enzyme markers like serum GGT could serve as cost effective biomarkers for carcinoma breast and help in early detection of progression of the disease. [Pratibha M NJIRM 2017; 8(4):53-57]
References
2. Strasak AM, Pfeiffer RM, Klenk J, et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int. J. Cancer: (2008) 123 (8), 1902–1906.
3. Whitfield JB. Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences 2001, Aug; 38(4):263-355.
4. Corti A, Duarte TL, Giommarelli C, et al. Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells. Mutation Research (2009) 669(1-2) 112–121. 5. Diergaarde B, Brand R, Lamb J. Et al. Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology. 2010;10(2-3):194-200.
6. Hanigan MH . Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis (1995) 16 (2): 181-185.
7. The Global Burden Of disease 2004 Update, World Health organization. [Last accessed on 2015 aug 19]. Available from: http://www.who.int/healthinfo/global burden disease/Global Health Risks report full.Pdf.
8. Statistics of Breast cancer in India [Last accessed on 2015 october 15] Available from http://www. breastcancerindia.net/ statistics/ trends.html .
9. Jarari AM, Shakila S., Alsoaeitiv SO, et al. Serum levels of LDH and Gamma GT in Libyan Breast Cancer patients. Indian journal of applied research. Dec 2013, 3 (12).
10. Pompella A, Dominici S, Pieri L, et al. Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -
independent iron uptake by cancer cells. Cancer Cell International 2003 May 14;3(1).
11. Van Hemelrijck M, Jassem W, Walldius G, et al. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer. 2011 Sep;47(13):2033-41
12. Chandrakanth KH, Nagaraj, Jayaprakash Murthy DS, et al. Study of serum levels of gamma- glutamyl transferase, lactate dehydrogenase, malondialdehyde and vitamin-e in breast cancer. International journal of pharma and bio sciences dec 2011, 2 (4).
13. Seth, S., Ravi, B., Randhawa, H.S. et al. Serum gamma glutamyl transpeptidase in breast cancer. Indian J Clin Biochem, January 1996, 11 (1), 49-51.
14. Choudhari A, Desai P, Indumati V, et al. Activities of serum Ada, GGT and alp in carcinoma breast-a case control study for diagnostic and prognostic significance. Indian J Med Sci 2013; 67:123-9..
15. Seth LR, Kharb S, Kharb DP. Serum biochemical markers in carcinoma breast. Indian J Med Sci. 2003 Aug;57(8):350-4.
16. Mishra S, D.C. Sharma DC, Sharma P. Studies of biochemical parameters in breast cancer with and without metastasis. Indian Journal of Clinical Biochemistry, 2004, 19 (1) 71-75.
